onkommon.com
A new model · annual · unbundled
Care that does not start at the diagnosis
Indian cancer care is bought in a panic, one invoice at a time. Membership buys the opposite: a relationship that already exists on the day something is found.
Three tiers
Pick the one that matches where you are
Each is annual, cancellable, and priced on its own. Nothing rolls into anything else.
Watch
₹78,000 / year
- Annual cancer risk assessment for each adult
- A written screening schedule, by age, sex, family history and exposure, not a standard panel
- One full screening panel per adult per year the age- and risk-appropriate panel, not a standard list
- Two specialty consultations included
- Records vault for the household
- Vaccination and screening recall, we contact you
- Priority booking across every clinic
For a family with no diagnosis who would rather not start from zero if one arrives.
Enquire about WatchNavigate
₹1,20,000 / year
- A named OnKommon Navigator, included
- Two tumour board listings included; further listings at member rate
- The cost desk, total course costing, biosimilar review, scheme documentation
- Records vault, plus two block or slide retrievals
- All written opinions at 50% of the published fee
- Priority urgent slots and same-day escalation
- Molecular advisory re-review as evidence and trials change
For someone in active treatment, here or anywhere else. Your oncologist keeps your case.
Enquire about NavigateFamily Shield
₹90,000 / year
- Genetic counselling for the index patient, pre and post test
- A written cascade plan naming who should be tested, in what order
- Coordination and counselling for up to six relatives, wherever they live
- A family letter any doctor in the country can act on
- A surveillance schedule for every identified carrier, with structured recall
- Annual re-review as classification and guidance change
The gap this closes: a variant is found, the family is told to get tested, and nobody ever does.
Enquire about Family ShieldNo bundling, stated line by line
What the fee covers, and what it never covers
A screening panel costs about ₹20,000. Membership does not hide that, it either includes a named number of panels, or it does not include them at all and says so.
| Item | Watch ₹78,000 |
Navigate ₹1,20,000 |
Family Shield ₹90,000 |
|---|---|---|---|
| Annual risk assessment & written screening schedule | Included · 2 adults | Included | Included · index patient |
| Screening panel (~₹20,000 each at partner rates) | One per adult, per year | Not included, ordered as clinically indicated | Not included, carrier surveillance ordered per schedule |
| Specialty consultations | Two included | Unlimited follow-up within the treatment phase | Counselling sessions included |
| OnKommon Navigator | Not included | Included, named | Coordination for cascade only |
| Tumour board listing | Not applicable | Two included, further at member rate | Not applicable |
| Written opinions | Published fee | 50% of published fee | Published fee |
| Records vault | Included · household | Included + two block retrievals | Included · family |
| Genetic counselling & cascade plan | Referral only | Referral only | Included · up to six relatives |
| Germline & molecular testing | Billed by OnKommon | Billed by OnKommon | Billed by OnKommon |
| Imaging, procedures, admission, medicines | Billed by the provider | Billed by the provider | Billed by the provider |
| Structured recall, we contact you | Included | Included | Included · every carrier |
Effective 1 September 2026, exclusive of applicable taxes. Screening panel cost is indicative and set by the diagnostics partner; the exact panel and price are confirmed before it is ordered. Membership can be cancelled, the unused portion of an annual fee is refunded pro rata.
Why membership rather than fee-per-visit
Because the failures are all about continuity
The things that go wrong in Indian cancer care are not usually clinical errors. They are gaps: a red flag nobody followed up, a screening interval nobody tracked, a relative who was told to get tested and never was, a patient discharged into nothing.
Every one of those is a continuity failure, and none of them can be fixed by an appointment. They are fixed by somebody being paid to keep the thread, which is exactly what a membership buys.
How membership sits with everything else
Four revenue surfaces, one patient relationship
Stated plainly, because a patient is entitled to know how the institution earns from them. The full model, with the arithmetic →
The decision
Consultation, boards, written opinions, genetic counselling. Highest margin, zero facility cost, and the only thing a competitor cannot assemble quickly.
Navigation & access
Coordination, records, cost and scheme work, recall, survivorship. Recurring by construction. Membership is this surface, sold annually.
The network
POAS subscriptions, white-label boards, certification, and employer contracts. Sold once, earns annually, reaches the country without buildings.
The science
Grants, public tenders, industry research programmes. Non-dilutive, and what makes the other three defensible rather than merely commercial.
Does it earn on the decision, on the movement, on the network, or on the science? If it earns on none of the four, it belongs to somebody else. And every rupee is paid for a defined service, actually rendered, at a stated price, on paper, never for a referral.
Membership is not required for anything
Every service on this site is available to buy on its own, at the published price. Membership exists because continuity is what actually fails, not because we want the relationship locked in.
